Inogen Debuts New Stationary Oxygen Concentrator in U.S.

Inogen Inc. has launched a new stationary oxygen concentrator (SOC), Voxi 5, designed to enhance access to high-quality oxygen therapy for U.S. patients under long-term care. Voxi 5 augments the company’s line of portable oxygen concentrators, significantly expanding its market potential while leveraging existing sales channels.

The Voxi 5 stationary oxygen concentrator combines affordability with durability, setting a new standard in oxygen therapy.

Developed in collaboration with Yuwell Medical, Voxi 5 presents a viable option for patients seeking reliable stationary oxygen therapy, delivering 1-5 L/min of quiet,¹ pure² continuous flow oxygen in a compact³ and efficient design. The device also features caster wheels to allow for worry free movement between rooms in the home, providing enhanced mobility and ease-of-use.

“With Voxi 5, we are fulfilling our mission to make respiratory care more accessible and empowering for patients,” Inogen President/CEO Kevin Smith stated. “This launch exemplifies our commitment to innovation, affordability, and enhancing the quality of life for those dependent on oxygen therapy.”

Voxi 5 complements the Inogen At Home product by offering a value-driven solution for price-sensitive customers or those in need of an additional unit for multi-room use. The Voxi 5 further offers patients and healthcare providers a reliable and efficient solution for managing chronic respiratory conditions.

Key features include quite operation, a compact design (lockable casters for ease of movement, a three-year sieve bed warranty,⁴ and advanced filtration (with a eight-layer internal gas pathway for delivering medical-grade oxygen).

Inogen Inc. is a global medical technology company offering respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing best-in-class respiratory therapy devices used to deliver care to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products widely available, allowing patients the chance to manage the impact of their disease.

Since its establishment in 1998, Yuwell has provided medical device solutions to enhance patient care and improve home healthcare worldwide. Yuwell generated more than $1 billion revenue in 2023, and has a broad product portfolio across respiratory treatment, diabetes management, electronic diagnostics products, first aid solutions and rehabilitation, amongst other areas. With nine R&D centers and seven advanced production facilities, Yuwell’s global presence spans over 100 countries and supports more than 300,000 healthcare institutions.

References
¹ 45dBA when measured at 2 m (6.6 ft) from device at 3 L/min and 5 L/min.
² Oxygen Concentration at 1-5 L/min: 87 – 96%.
³ Device height of 16.7in.
⁴ Three-Year Sieve Bed Warranty for a total of 8,000 hours.